An observational study in Trauma, sponsored by Methodist Health System. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-10.
Sponsored by Methodist Health System · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This retrospective data repository will serve as a means to aggregate and analyze best practices as relative to traumatic colon injury outcomes.
The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to traumatic colon injuries and evaluate current surgical management as treatment, specifically comparing initial primary anastomosis, delayed anastomosis, and ostomy diversion outcomes.
2,217 studies on the registry are indexed under Wounds and Injuries; 440 are open to participants now.
This study's planned enrollment of 100 is below the median of 169 across 690 observational studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →Methodist Health System is the lead sponsor of 170 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All trauma patients at Methodist Dallas Medical Center (MDMC) diagnosed with traumatic colon injury and meets registry inclusion
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
18 years old Included in the MDMC(Methodist Dallas Medical Center) Trauma Registry Any diagnosis code indicative of injury to the large and/or small bowel (S36.5 and/or S36.4)
Exclusion Criteria:
\<18 years old Prisoners, pregnant persons, or other protected population.
Include all trauma patients at Methodist Dallas Medical Center (MDMC) diagnosed with traumatic colon injury and meets registry inclusion. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.
Other: Medical/Phenotype Data Collection Procedures & Data to be Collected
The Methodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.
Total Number of Study Sites
This study will include all trauma patients at Methodist Dallas Medical Center diagnosed with traumatic colon injury and meets registry inclusion.
Time frame: 5 years
Plan to share: Yes — All information will be blinded in compliance with Good Clinical Practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of protected health information or research information. Only de-identified protected health information will be shared in relevant research mediums.
Supporting information: Study protocol
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Jan 2027, 35 months after the start.
Of 265 non-industry observational studies under Wounds and Injuries, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's planned 35 months is above that.
Counting every sponsor, half of 312 studies reached it within 28 months; a quarter within 12 and three quarters within 60.
Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.